Skip to main content
Top
Published in: Annals of Surgical Oncology 3/2018

01-12-2018 | ASO Author Reflections

ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas

Authors: John F. Thompson, MD, Richard A. Scolyer, MD, Serigne N. Lo, PhD

Published in: Annals of Surgical Oncology | Special Issue 3/2018

Login to get access

Excerpt

The risk of death due to thin melanomas (≤ 1.0 mm) that have been treated by wide excision with adequate margins is generally considered to be extremely low; however, more patients ultimately die of thin melanomas than of thicker melanomas. This is principally because, although the risk of death for an individual patient with a thin melanoma may be low, the great majority of those who develop a melanoma present with thin tumors. Also relevant is the consideration that if recurrence does occur, it tends to be much later than in patients with thicker melanomas, with deaths due to thin melanomas still occurring more than 20 years after initial presentation. It is therefore important to risk-stratify patients with thin melanomas to guide their management and follow-up. In our study,1 we sought to determine whether there was an identifiable cut-point separating higher-risk from lower-risk thin melanomas, and to accurately assess long-term survival outcomes (> 10 years) for patients with these tumors. …
Literature
1.
go back to reference Lo SN, Scolyer RA, Thompson JF. Long-term survival of patients with thin (T1) cutaneous melanomas: a Breslow thickness cut point of 0.8 mm separates higher-risk and lower-risk tumors. Ann Surg Oncol. 2018;25:894–902.CrossRefPubMed Lo SN, Scolyer RA, Thompson JF. Long-term survival of patients with thin (T1) cutaneous melanomas: a Breslow thickness cut point of 0.8 mm separates higher-risk and lower-risk tumors. Ann Surg Oncol. 2018;25:894–902.CrossRefPubMed
2.
go back to reference Amin MB, Edge SB, Greene FL, Carducci MA, Compton CA (eds). AJCC cancer staging manual. 8th ed. New York: Springer International Publishing; 2017. Amin MB, Edge SB, Greene FL, Carducci MA, Compton CA (eds). AJCC cancer staging manual. 8th ed. New York: Springer International Publishing; 2017.
3.
go back to reference Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer Eighth Edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92CrossRefPubMedCentralPubMed Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI, et al. Melanoma staging: evidence-based changes in the American Joint Committee on Cancer Eighth Edition cancer staging manual. CA Cancer J Clin. 2017;67(6):472–92CrossRefPubMedCentralPubMed
4.
go back to reference Mihic-Probst D, Shea C, Duncan L, de la Fouchardiere A, Landman G, Landsberg J, et al. Update on thin melanoma: outcome of an international workshop. Adv Anat Pathol. 2016;23:24–9.CrossRefPubMed Mihic-Probst D, Shea C, Duncan L, de la Fouchardiere A, Landman G, Landsberg J, et al. Update on thin melanoma: outcome of an international workshop. Adv Anat Pathol. 2016;23:24–9.CrossRefPubMed
Metadata
Title
ASO Author Reflections: Long-Term Survival of Patients with Thin (T1) Cutaneous Melanomas
Authors
John F. Thompson, MD
Richard A. Scolyer, MD
Serigne N. Lo, PhD
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2018
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-018-7014-4

Other articles of this Special Issue 3/2018

Annals of Surgical Oncology 3/2018 Go to the issue